Arkolith/Insider Trading/DNTH/Form 4

Soteropoulos Paula

DirectorDianthus Therapeutics, Inc. /DE/ (DNTH) · full profile →Form 4 · filed Mar 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.2M
Net Open-Market Flow
-$2.2M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 24, 2026Sell(S)28K$78.05$2.2M0
Mar 24, 2026Option exercise(M)28K$8.44$233K28K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 24, 2026Option exercise(M)28K—$01K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001692444-26-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML